|
Volumn 115, Issue 15, 2007, Pages
|
Letter by Padfield et al regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia after cardiac surgery) study" [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
PLACEBO;
CLINICAL TRIAL;
HEART ATRIUM FIBRILLATION;
HEART SURGERY;
HEART VALVE SURGERY;
HUMAN;
LETTER;
MULTIVARIATE ANALYSIS;
OUTCOME ASSESSMENT;
PERIOPERATIVE PERIOD;
POSTOPERATIVE CARE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
TREATMENT RESPONSE;
ATRIAL FIBRILLATION;
CARDIAC SURGICAL PROCEDURES;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
POSTOPERATIVE COMPLICATIONS;
PYRROLES;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
|
EID: 34247277743
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.106.667253 Document Type: Letter |
Times cited : (3)
|
References (4)
|